Campaign India Team
Apr 25, 2019

Amol Dighe joins Madison Media Ultra as CEO

Also appointed as head investments for Madison Media Group

Amol Dighe joins Madison Media Ultra as CEO
Madison Media has announced the appointment of Amol Dighe as chief executive officer at Madison Media Ultra. Madison Media Ultra is the unit which handles the Godrej and Marico account at the agency. 
Dighe has also been given the head of investments mandate for Madison Media Group. His last stint was with CA Media. 
Vikram Sakhuja, partner and group CEO Madison Media and OOH, said, “We are delighted to have an experienced professional like Amol join our Madison Media leadership team and am confident that with his width of experience, Amol is going to contribute significantly toour key clients and to Madison.”
Dighe said, “I am delighted to be a part of this Iconic media company, ably led by industry stalwarts. Its highly motivating to work on clients with such amazing pedigree. Looking forward to doing great work which helps our clients in growing their brands.”
In a career spanning 22 years he has also worked with The Times of India, Mindshare Fulcrum, Star TV, Mindshare (Indonesia), Omnicom Media Group and Amagi. 
Campaign India

Related Articles

Just Published

12 hours ago

IPG Mediabrands launches global ecommerce unit ...

In India Interactive Avenues - A Reprise Network Company will lead the ecommerce offering

17 hours ago

Twitter ad revenue bolstered by return of events

Advertisers return to Twitter as product launches and live events begin to resurface worldwide.

17 hours ago

Amazon triples net income, nears $100 billion in ...

International operations turned a profit of $407 million, while revenue for the company's 'other' category, which is mainly its advertising services, grew 50% year over year.

17 hours ago

Facebook ad revenue boosted by commerce uptick

APAC led user growth, as Mark Zuckerberg said Facebook benefits from people and businesses "relying" on its platforms to stay connected and make money during Covid-19.